XML 29 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Common Stock
Treasury Stock
Additional Paid In Capital
Retained Earnings
Accumulated Other Comprehensive Income
Parent Company
Total
Balance at Dec. 31, 2012         $ (350) $ 3,713 $ 3,363
Beginning balance at Dec. 31, 2012         (350)    
Increase (Decrease) in Stockholders' Equity              
Separation-related adjustments     $ (1,316)   (662) 707 (1,271)
Reclassification of parent company net investment in connection with separation     4,420     $ (4,420)  
Issuance of common stock at separation $ 16   (16)        
Issuance of common stock at separation (in shares) 1,577            
Net earnings       $ 4,128     4,128
Other comprehensive income (loss), net of tax         570   570
Dividends declared       (2,561)     (2,561)
Share repurchases   $ (223)         $ (223)
Share repurchases (in shares) (4)           (4)
Stock-based compensation plans and other   (97) 583       $ 486
Stock-based compensation plans and other (in shares) 14            
Ending balance at Dec. 31, 2013 $ 16 (320) 3,671 1,567 (442)   4,492
Balance (in shares) at Dec. 31, 2013 1,587            
Increase (Decrease) in Stockholders' Equity              
Net earnings       1,774     1,774
Other comprehensive income (loss), net of tax         (1,589)   (1,589)
Dividends declared       (2,806)     (2,806)
Share repurchases   (550)         $ (550)
Share repurchases (in shares) (9)           (9)
Stock-based compensation plans and other   (102) 523       $ 421
Stock-based compensation plans and other (in shares) 13            
Ending balance at Dec. 31, 2014 $ 16 (972) 4,194 535 (2,031)   1,742
Balance (in shares) at Dec. 31, 2014 1,591            
Increase (Decrease) in Stockholders' Equity              
Net earnings       5,144     5,144
Other comprehensive income (loss), net of tax         (530)   (530)
Dividends declared       (3,431)     (3,431)
Common shares issued to Pharrmacyclics Inc. stockholders $ 1   8,404       8,405
Common shares issued to Pharrmacyclics Inc. stockholders (in shares) 128            
Share repurchases   (7,774)         $ (7,774)
Share repurchases (in shares) (119)           (46)
Stock-based compensation plans and other   (93) 482       $ 389
Stock-based compensation plans and other (in shares) 10            
Ending balance at Dec. 31, 2015 $ 17 $ (8,839) $ 13,080 $ 2,248 $ (2,561)   $ 3,945
Balance (in shares) at Dec. 31, 2015 1,610